News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Bold Leadership and Vision: Why Dr. Narjust Florez Deserves Undesignated IASLC Board Seat #4 – Florez Lab
Narjust Florez/X
May 9, 2025, 11:07

Bold Leadership and Vision: Why Dr. Narjust Florez Deserves Undesignated IASLC Board Seat #4 – Florez Lab

Florez Lab shared a post on X:

“Dr. Narjust Florezis the leader we need on the IASLC Board. Visionary. Inclusive. Fearless. Need more reasons to vote for Dr. Florez?
– She has a vision
– She takes action
– She has a track record of impact Let’s bring her voice to the IASLC Board!!! Ring ring….
Undesignated Board Seat #4 is calling! Voting is happening until May 22nd.”

Proceed to the video attached to the post.

More posts featuring Florez Lab on OncoDaily.

cancer Florez Lab Narjust Florez OncoDaily Oncology
Special Coverage
Oncolibrary
Jul 7, 2025, 16:44
Botensilimab and Balstilimab Achieves 21-Month Survival in mCRC and FDA Endorsement for Global Phase 3 Trial
Blog
Jul 7, 2025, 16:07
IV Research Day Dedicated to Clinical Research Will Be Held on October 6 - European Institute of Oncology
Oncolibrary
Jul 7, 2025, 15:48
Why Colonoscopy Is the Gold Standard in Early Detection of Colon Cancer Screening
Science
Jul 7, 2025, 15:44
Giuseppe Minniti: Happy to Introduce a New Proof of Concept - Strategic Radiotherapy
Oncolibrary
Jul 7, 2025, 15:12
MASCC 2025 Highlights: Long-Term Outcomes from RCT of Mepitel Film in Breast Cancer Radiotherapy
Blog
Jul 7, 2025, 15:05
Meet Josee, an Incredible Participant in the Training of Trainers Workshop on Palliative Care - ACREOL Global
Oncolibrary
Jul 7, 2025, 14:52
Botensilimab and Balstilimab Show Durable Survival in MSS Colorectal Cancer: ESMO GI 2025 Update
Science
Jul 7, 2025, 14:51
Reirradiation Techniques, Survival Outcomes, Dose, and Toxicity in Gynecological Cancers by Dina Najjari et al.
Blog
Jul 7, 2025, 14:51
First Annual Sam-a-palooza Raised $8,000 Through Donations and Registrations - Cholangiocarcinoma Foundation
Science
Jul 7, 2025, 14:34
Fabio Girardi: The Omission of Anthracyclines for the Adjuvant Treatment of Women with TNBC
Blog
Jul 7, 2025, 14:21
Enduring Partnerships among Cancer Survivors, Advocates, and Scientists with the AACR Scientist-Survivor Program
Science
Jul 7, 2025, 14:13
Hung Trinh: First In-Depth Comparative Biomonitoring of CAR-T in Multiple Myeloma Patients